Our Executive Management Team focuses on the day-to-day operation of Salix Pharmaceuticals.
Carolyn J. Logan
President and Chief Executive Officer
Ms Logan has served as Salix President and Chief Executive Officer and as a member of the Board of Directors since July 2002. She previously served as Senior Vice President, Sales and Marketing, from 2000 to July 2002. Ms Logan has approximately 35 years of specialty pharmaceutical sales and marketing experience, including extensive experience building and/or rebuilding specialty pharmaceutical sales forces. Before joining Salix, she served as Vice President, Sales and Marketing, of the Oclassen Dermatologics division of Watson Pharmaceuticals, Inc, from May 1997 to June 2000, and as Vice President, Sales, from February 1997 to May 1997. Before that date, she served as Director, Sales, of Oclassen Pharmaceuticals, Inc, from January 1993 to February 1997. Before joining Oclassen, Ms Logan held various sales and marketing positions of increasing responsibility with Galderma Laboratories, Ulmer Pharmacal, and Westwood-Squibb Pharmaceuticals, Inc, a subsidiary of Bristol-Myers Squibb. Ms Logan received a BS in Biology and Dental Hygiene from the University of North Carolina at Chapel Hill.
Adam C. Derbyshire
Executive Vice President, Finance and Administration, and Chief Financial Officer
Mr Derbyshire joined Salix in June 2000, bringing extensive pharmaceutical industry experience in finance, accounting, investor relations, and general corporate matters. Before joining Salix, Mr Derbyshire was Vice President, Corporate Controller, and Secretary of Medco Research, Inc, (acquired by King Pharmaceuticals, Inc, in February 2000) from June 1999 to June 2000, and Corporate Controller and Secretary from September 1995 to June 1999. Before that, he served as Assistant Controller of Medco Research from October 1993 to September 1995. Mr Derbyshire received a BS degree from the University of North Carolina at Wilmington and an MBA from the University of North Carolina at Charlotte.
William P. Forbes, PharmD
Executive Vice President, Medical, Research and Development, and Chief Development Officer
Dr Forbes joined Salix in January 2005 as Vice President, Research and Development,
and Chief Development Officer, bringing more than 20 years of experience in pharmaceutical
development. Dr Forbes was promoted to Senior Vice President in 2009 and currently is our Executive Vice President,
Medical, Research and Development, and Chief Development Officer. Before joining Salix, Dr Forbes served as Vice President,
Clinical Development and Regulatory Affairs, at Metabasis Therapeutics, Inc. Before that, he served as a Group Leader at Otsuka
America Pharmaceutical, Inc, since 1996, and held various senior management positions in clinical research at Otsuka since 1991.
Before joining Otsuka, Dr Forbes served as Senior Clinical Research Scientist at Glaxo, Inc. Dr Forbes has had responsibilities
involving the clinical research and development of numerous new chemical entities in a variety of therapeutic indications, including
gastroenterology and infectious disease. Dr Forbes received a PharmD from Creighton University and conducted postdoctoral work at the Creighton Cardiac Center and the Cardiovascular Clinical Research Department at Glaxo.
Rick D. Scruggs
Executive Vice President, Business Development
Mr Scruggs joined Salix in 2000 as Director, National Accounts, bringing extensive experience in business development and commercial activities in the pharmaceutical industry. Mr Scruggs was promoted to Senior Vice President in 2009 and to Executive Vice President in 2011. Before joining Salix, Mr Scruggs served as Director of Managed Markets at Watson Pharmaceuticals, Inc, from May 1997 to July 2000. Prior to that, Mr Scruggs served as Director, Managed Markets and Trade, at Oclassen Pharmaceuticals, Inc, from January 1995 to February 1997. Before joining Oclassen, Mr Scruggs held various sales and marketing positions of increasing responsibility with Johnson & Johnson and Ciba-Geigy. Mr Scruggs received a BS in Criminal Justice from Appalachian State University.